en

PRODUCT DETAIL

Eylea 40 mg/ml, injekčný roztok naplnený v injekčnej striekačke

Code 3406A
MA number EU/1/12/797/001
Product Form: sol inj 1x0,09 ml/3,6 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 64 - OPHTHALMOLOGICA
ATC:
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L Ocular vascular disorder agents
S01LA Antineovascularisation agents
S01LA05 Aflibercept
Shelf life: 24
Route of admin.: Intravitreal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.11.2012
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.01.2024
eu-flag.png sk-flag.png